Bruce E Torbett

Attenuation of HIV-1 Replication in Primary Human Cells with a Designed Zinc Finger Transcription Factor*

David J Segal, João Gonçalves, C. Barbas, 2004, Journal of Biological Chemistry.

Is resistance futile?

John H Elder, B. Torbett, D. Sheeter, 2003, Current drug targets. Infectious disorders.

Identification of broad-based HIV-1 protease inhibitors from combinatorial libraries.

Sukwon Hong, Rolf Muller, Dale L Boger, 2010, The Biochemical journal.

Regulation of neutrophil and eosinophil secondary granule gene expression by transcription factors C/EBP epsilon and PU.1.

H Phillip Koeffler, B. Torbett, H. Koeffler, 2003, Blood.

Accessory mutations maintain stability in drug-resistant HIV-1 protease.

B. Torbett, Bruce E Torbett, Max W Chang, 2011, Journal of molecular biology.

The Proteome of Mouse Brain Microvessel Membranes and Basal Lamina

Andrew Baird, J. Yates, B. Torbett, 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Rapid deep sequencing of patient-derived HIV with ion semiconductor technology.

Glenn Oliveira, Jinyun Yuan, B. Torbett, 2013, Journal of virological methods.

The Transcription Factor Encyclopedia

Debra L. Fulton, Henriette O'Geen, Elodie Portales-Casamar, 2012, Genome Biology.

CCR5 Disruption in Induced Pluripotent Stem Cells Using CRISPR/Cas9 Provides Selective Resistance of Immune Cells to CCR5-tropic HIV-1 Virus.

B. Torbett, I. Slukvin, Bruce E Torbett, 2015, Molecular therapy. Nucleic acids.

A cleavage enzyme-cytometric bead array provides biochemical profiling of resistance mutations in HIV-1 Gag and protease.

Joseph Trotter, S. Breuer, B. Torbett, 2011, Biochemistry.

Structural basis for drug and substrate specificity exhibited by FIV encoding a chimeric FIV/HIV protease.

Arthur J Olson, C David Stout, John H Elder, 2011, Acta crystallographica. Section D, Biological crystallography.